论文部分内容阅读
[答]T_3优势Graves病最早是在1984年由Takamatsu等提出。系指部份T_3与T_4水平增高的Graves病患者,经抗甲状腺药物适当治疗后,T_4虽已降至正常,而T_3仍过高,其T_3/T_4>30(nmol/μmol)者称之为T_3优势Graves病。此病强调经抗甲状腺药物适当治疗后的T_3/T_4比值,可能区别于T_3型甲亢。
[A] T_3 advantage Graves disease was first proposed in 1984 by Takamatsu et al. Refers to the part of T_3 and T_4 levels increased in patients with Graves after appropriate treatment with anti-thyroid drugs, although the T_4 has been reduced to normal T_3 is still too high, its T_3 / T_4> 30 (nmol / μmol) who called T_3 advantage Graves disease. The disease emphasizes the T_3 / T_4 ratio after proper treatment of anti-thyroid drugs may be different from T_3-type hyperthyroidism.